Improvements in Children's Oncology Group Neuroblastoma Risk Stratification Through a Change in Age Cut-off and Use of INRGSS
Overview
Overview
Journal
Transl Pediatr
Publisher
AME Publishing Company
Specialty
Pediatrics
Date
2024 Nov 11
PMID
39524386
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Naranjo A, Irwin M, Hogarty M, Cohn S, Park J, London W
. Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System. JCO Clin Cancer Inform. 2019; 2:1-15.
PMC: 6421832.
DOI: 10.1200/CCI.17.00140.
View
2.
Perez-Garcia M, Segura M
. Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients. Transl Pediatr. 2023; 12(11):1926-1930.
PMC: 10730960.
DOI: 10.21037/tp-23-391.
View
3.
Balyasny S, Lee S, Desai A, Volchenboum S, Naranjo A, Park J
. Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma. JAMA Netw Open. 2021; 4(7):e2116248.
PMC: 8267607.
DOI: 10.1001/jamanetworkopen.2021.16248.
View
4.
Bender H, Irwin M, Hogarty M, Castleberry R, Maris J, Kao P
. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. J Clin Oncol. 2023; 41(17):3149-3159.
PMC: 10256433.
DOI: 10.1200/JCO.22.01946.
View
5.
Sokol E, Desai A, Applebaum M, Valteau-Couanet D, Park J, Pearson A
. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. J Clin Oncol. 2020; 38(17):1906-1918.
PMC: 7280049.
DOI: 10.1200/JCO.19.03285.
View